Your cart is empty.
Männedorf, Switzerland, September 23, 2010 – The Clinical Pharmacology Department in the Mahidol-Oxford Tropical Medicine Research Unit (MORU), Bangkok, Thailand, has chosen Tecan’s Freedom EVO® platform to automate research into the pharmacology of anti-malarial and anti-influenza drugs. Professor Niklas Lindegardh, Head of Department, explained: “Our studies focus on malaria and influenza, and the main thrust of our research is the development of new methods and assays to quantify these drugs in biological fluids. Our Freedom EVO liquid handling workstation performs aliquoting and preparation of patient samples, automating a range of preparation methods, such as solid-phase or liquid-liquid extractions and protein precipitations. We have been able to move from performing all these steps manually to automating everything on the Freedom EVO 200, and analyses that previously took around five hours now take only 20 minutes for 96 samples.”
“The platform configuration was tailored to fulfill our exact requirements and we worked with engineers from Tecan Singapore to set up the system and program the basic structure of the process scripts. We have since been able to refine the scripts, creating new processes and fine tuning the system to accommodate our sample preparation requirements. Overall, the platform is reliable and we are very happy with the support we receive from Tecan; they always respond quickly to our needs,” concluded Professor Lindegardh.
To find out more on Tecan’s Freedom EVO workstations, visit www.tecan.com/freedomevo
For more information please contact
Tecan Trading AG
Tel +41 (0)44 922 81 11
Fax +41 (0)44 922 81 12
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).